Medical Device - Product Classification

Understanding FDA Device Classes

In the U.S., the FDA categorizes medical devices into three classes based on risk:

Class I — Low Risk

• Minimal potential for harm
• Subject to general controls
• Often exempt from premarket review

Class II — Moderate Risk

• Requires additional controls and performance standards
• Typically requires 510(k) clearance

Class III — High Risk

• Life-sustaining or high-impact devices
• Requires Premarket Approval (PMA) and clinical evidence

The higher the risk, the greater the regulatory burden—and the longer the path to market.

The Challenge: Classification Isn’t Always Obvious

Many products fall into gray areas.

• Is it a medical device—or a consumer product?
• Is it software (SaMD), a combination product, or something else?
• Does a predicate device exist—or do you need a De Novo pathway?
• Could your claims unintentionally increase your classification risk?

Even small changes in intended use or labeling can shift your classification—and dramatically impact your regulatory requirements.

How RQMIS Helps

We go beyond basic classification—we help you make strategic decisions that reduce risk and accelerate approval.

Comprehensive Classification Analysis

We evaluate your:

• Intended use and indications
• Technology and mechanism of action (PMOA)
• Risk profile and potential failure modes
• Software and digital components

Predicate Device & Market Analysis

We identify and analyze similar products to:

• Determine the most appropriate classification
• Support a 510(k) strategy when possible
• Avoid unnecessary regulatory burden

Regulatory Strategy Alignment

Classification doesn’t stand alone—we align it with your broader strategy:

• Optimal pathway selection (510(k), De Novo, PMA)
• Testing and clinical evidence planning
• Submission strategy and timeline

FDA Interaction & RFD Support

If your product falls into a gray area, we support:

• Request for Designation (RFD) submissions
• Regulatory justification and documentation
• Direct engagement with FDA to confirm classification

Real Impact: Getting Classification Right

In one case, RQMIS helped a client avoid unnecessary FDA regulation entirely by refining product claims—saving significant time, cost, and effort.

That’s the difference between guessing—and getting it right the first time.

The Outcome

With RQMIS, you gain:

• A clear, defensible classification strategy
• Reduced regulatory risk and uncertainty
• Faster, more efficient path to market
• Alignment between product, claims, and compliance

Don’t Let Classification Slow You Down

The earlier you define your classification, the more control you have over your timeline, costs, and regulatory success.